Monday, 12 May 2008

Merck gets Indian patent for upcoming drugs

Pharma giant Merck & Co Inc has received patent approval from the Indian Patent Office for two of its upcoming drugs for dyslipidemia and obesity. The two new-patented drugs are in final stages of trial and are yet to receive the Drug Controller General of India’s (DCGI) (Link)

Posted by ADKS at 10:26 am

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker